Ghost Tree Capital »

Eyepoint Pharmaceuticals shares owned by Ghost Tree Capital

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Ghost Tree Capital from 13F filings

Historical chart of Ghost Tree Capital investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Ghost Tree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Ghost Tree Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $2.6M 325k 7.99

More positions owned by Ghost Tree Capital

Moonlake Immunotherapeutics Class A Ord (MLTX)
Sarepta Therapeutics (SRPT)
Spdr Ser Tr S&p Biotech Call Option (XBI)
Akero Therapeutics (AKRO)
Krystal Biotech (KRYS)
Madrigal Pharmaceuticals (MDGL)
Tg Therapeutics (TGTX)
Immunovant (IMVT)
Ascendis Pharma A/s Sponsored Adr (ASND)
Axsome Therapeutics (AXSM)
Alpine Immune Sciences (ALPN)
Syndax Pharmaceuticals (SNDX)
Vaxcyte (PCVX)
Tarsus Pharmaceuticals (TARS)
Apellis Pharmaceuticals Call Option (APLS)

View all positions for Ghost Tree Capital

Top funds holding Eyepoint Pharmaceuticals

Cormorant Asset Management
Franklin Resources
T. Rowe Price Associates
Vanguard Group
Citadel Advisors
Perceptive Advisors
Millennium Management
Jennison Associates
Ikarian Capital
Deutsche Bank Aktiengesellschaft
Federated Investors
Fiera Capital Corporation
Laurion Capital Management
UBS Group
Goldman Sachs Group

View all funds holding Eyepoint Pharmaceuticals